click below
click below
Normal Size Small Size show me how
Pharm-Chpt 28
Pharmacology
| Question | Answer |
|---|---|
| 2 categories of neuromuscular junction blockers | nondepolarizing and depolarizing |
| Nondepolarizing neuromuscular junction blockers act as? where? | act as antagonist to ACh at neuromuscular junction |
| Nondepolarizing neuromuscular junction blockers prevent? | prevent depolarization of muscle cells |
| Depolarizing neuromuscular junction blockers act as? | act as ACh agonist |
| Depolarizing neuromuscular junction blockers stimulate? | stimulate muscle cell |
| Depolarizing neuromuscular junction blockers prevent? | prevent cell from repolarizing |
| Neuromuscular junction blockers cause? then have to? | cause paralysis-- so perform surgery and facilitate mechanical ventilation |
| Nondepolarizing NMJB similar in structure to? | similar in structure to ACh |
| Nondepolarizing NMJB occupy? | occupy muscular cholinergic receptor site |
| Nondepolarizing NMJB-- ACh cannot react with receptor at cholinergic receptor site.T/F | True |
| Nondepolarizing NMJB- no what? (2) | no activation of muscle cells and no contraction |
| Not broken down by cholinesterase. | Nondepolarizing NMJB |
| Longer lasting than ACh | Nondepolarizing NMJB |
| Prototype for Nondepolarizing NMJ Blockers | Pancuronium(Pavulon) |
| Pavulon indication | as an adjunct to gen. asthetics to induce skeletal muscle relaxation; to reduce the intensity of muscle contractions in electroconvulsive therapy, to facilitate teh care of patients undergoing mechanical ventilation |
| Adverse reactions of Pavulon | respiratory depression, apnea, broncospasm, cardiac arrhythmias |
| Neuromuscular junction blocking agents are structurally similar to? | structurally similar to ACh |
| Neuromuscular junction blocking agents compete with? | compete with ACh for muscle ACh receptor sites |
| Is hydrophilic. | Neuromuscular junction blocking agents |
| Hydrophilic means? | does not cross blood brain barrier |
| Neuromuscular junction blocking agents are adjunct to? | adjunct to general ansthesia |
| Neuromuscular junction blocking agents facilitate? | facilitate intubation and electroconvulsive therapy |
| Neuromuscular junction blockers prevent? | prevent resistance to ventilator |
| Caution for neuromuscular junction blocking agents | malignant hyperthermia(patient/family), genetic or disease related low cholinesterase(cirrhosis and malnutrition) |
| Adverse reactions of neuromuscular junction blocking agents | respiratory depression, bronchospasm, GI slowdown, fear related to helplessness, inability to communicate |
| Prototype for depolarizing NMJ Blocker | Succinylcholine(Anectine, Quelicin) |
| Indication of Succinylcholine | as an adjunct to gen. anesthesia, to facillitate endotracheal intubation, to induce skeletal muscle relaxation during surgery or mechanical ventilation |
| Adverse effects of Succinylcholine | muscle pain, relatd to contraction of the muscles as a first reaction, respiratory depression,apnea |
| Nursing implication for Neuromuscular junction blocking agents(part 1) | -assess for HX of malignant hyperthermia(dantolene available, cooling measures) -have cholinesterase inhibitor available(reduce excessive neuromuscular blockade caused by nondepolarizing neuromusuclar junction blockers |
| Nursing implication for neuromuscular junction blocking agents(part 2) | monitor closely, provide comfort measures |